The Easy way to reduce costs in drug manufacturing

Reduce Manufacturing Costs Without Compromising Product Quality

In the pharmaceutical industry, expiring patents, changes in regulations and increasing competition are leading to shrinking margins. In addition, the rapid rise of healthcare across the developing world is further hurting drug companies as governments try to contain escalating costs. It is not surprising then that pharmaceutical companies are scrutinizing their expenditures across the value chain.

The benefits of in-line process analytics over periodically measuring grab samples in the laboratory is universally accepted, and pharmaceutical companies gain significantly from the continuous, real-time data, and reduced workload that in-line analytics bring. But what is next? What more can in-line analytics do to cut drug production costs?

The answer is digital technology.